Skip to main content
Clinical Trials/CTRI/2023/07/055371
CTRI/2023/07/055371Not yet recruitingNot Applicable

A Comparative Clinical Study of Agnikarma and Twagadi Gutika in Greeva Sandhigata Vata(Cervical Spondylosis)

Uttarakhand Ayurved University1 site in 1 country32 target enrollmentStarted: July 27, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
32
Locations
1
Primary Endpoint
• Radiation of Pain

Study Overview

Brief Summary

Sandhigata Vata is one of the commonest joint disorders, broadly

described under Vata Vyadhi which effect Musculo-skeletal system of the

body. Sandhigata Vata is a disease of Sandhi (joint) with symptoms of

Sandhi Shoola, Sandhi Shotha, Vedana during Akunchana, Prasarana and

in a later stage Hanti Sandhigatah.When Greeva Pradesh is affected, it

termed as Greeva Sandhigata Vata or Cervical Spondylosis. Acharya

Sushruta has mentioned Agnikarma having Vata-kaphahara property like

Ushna, Sukshma, Ashukari Guna. So, it has been chosen to manage

Sandhigata Vata. As Agnikarma may be effectively helpful to relieve the

pain and muscle spasm instantly so it is used to manage cervical

spondylosis. Twagadi Gutika is described in Gadhnigrah, in the management of Vatavyadhi.

AIM AND OBJECTIVES

  1. To compare the efficacy of Agnikarma and Twagadi Gutika in Cervical Spondylosis.

  2. To decrease the intensity of pain, stiffness and weakness so that the patient can do his routine work comfortably.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients having clinical features such as pain in cervical region, stiffness, restricted movement of neck, tingling sensation and numbness in upper extremities.
  • •X-Ray showing radiological signs for Cervical Spondylosis.

Exclusion Criteria

  • •Infectious diseases of the Cervical spine.
  • •Fracture or dislocation in cervical region.
  • •Patients with cervical myelopathy, neoplastic growth or history of trauma.
  • •Pregnant/lactating women.
  • •RA factor positive cases.

Outcomes

Primary Outcomes

• Radiation of Pain

Time Frame: 28 days

• Neck Pain

Time Frame: 28 days

• Vertigo

Time Frame: 28 days

It will be assessed on the basis of relief in

Time Frame: 28 days

following parameters -

Time Frame: 28 days

• Stiffness

Time Frame: 28 days

• Weakness

Time Frame: 28 days

• Tenderness over cervical region

Time Frame: 28 days

• Movements of the neck

Time Frame: 28 days

Secondary Outcomes

  • Improve in radiological findings(28 days)

Investigators

Sponsor
Uttarakhand Ayurved University
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials